Amethyst Health of Wausau: Medication Delay Violation - WI
The resident, identified in inspection records only as R2, had been admitted to the facility with a diagnosis that includes muscle weakness as a core symptom. Multiple sclerosis causes the immune system to attack the protective coverings of nerves, and muscle spasms are among the most debilitating effects for people living with the disease.
On August 16, 2025, a physician ordered Methocarbamol, a muscle relaxant, at 500 milligrams four times a day to treat R2's spasms.
The medication never arrived.
Starting with the morning dose on August 17 and continuing through the evening and bedtime doses on August 18, nursing staff documented a "9" on R2's medication administration record for each missed dose. In the facility's electronic records, a nursing progress note explained the reason: the Methocarbamol was on hold because delivery was pending.
Six missed doses across two days. The physician who ordered the medication was not notified.
A licensed practical nurse confirmed the findings to inspectors during an interview on the evening of August 19. The interim director of nursing, interviewed later the same night, acknowledged what the standard should have been: when a nurse cannot administer the first dose of a newly ordered medication, the prescribing physician should be told.
That notification never happened.
The deficiency was cited at a level of minimal harm or potential for actual harm, meaning inspectors determined R2 had not yet suffered documented injury from the gap in treatment. But for a resident whose diagnosis directly causes the muscle spasms the medication was prescribed to control, two days without it is not an abstraction.
Inspectors completed the complaint survey on August 19, 2025. The facility, located at 1010 East Wausau Avenue, is a Medicare and Medicaid certified provider.
What the inspection record does not say is whether R2 experienced increased spasms during those two days. It does not say whether anyone checked on R2 with that question in mind, or whether anyone thought to ask. The nursing notes recorded a logistical explanation. They did not record what R2 felt.
The interim director of nursing told inspectors what the nurse should have done. She did not say why it hadn't been done, or how many times a similar gap might go unnoticed when a medication is simply listed as pending and no one picks up the phone.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Amethyst Health of Wausau from 2025-08-19 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: August 5, 2026 · Our methodology
AMETHYST HEALTH OF WAUSAU in WAUSAU, WI was cited for violations during a health inspection on August 19, 2025.
The resident, identified in inspection records only as R2, had been admitted to the facility with a diagnosis that includes muscle weakness as a core symptom.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.